BIOLOGICAL TESTING FACILITY - DMAU CLINICAL SUPPLIES AND STABILITY TESTING OF DMAU CAPSULES

生物测试设施 - DMAU 临床用品和 DMAU 胶囊的稳定性测试

• 批准号: 8937289
• 负责人: KAREN STEINMETZ
• 金额: $ 100.4万
• 依托单位: SRI INTERNATIONAL
• 依托单位国家: 美国
• 财政年份: 2012
• 资助国家: 美国
• 起止时间: 2012-09-28 至 2015-09-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8937289
• 关键词: Animals; Apidae; Apis; Biological; Biological Testing; Castor Oil; Clinical; Clinical Trials; Contraceptive Agents; Contractor; Development; Devices; Dosage Forms; Dose; Drug Formulations; Endocrine; Equipment; Evaluation; Fertility; Funding; Government; Human; Human Resources; Investigation; Pharmaceutical Preparations; Placebos; Powder dose form; Preparation; Qualifying; Quality Control; Regulation; Route; Services; Shipping; Ships; System; Testing; Validation; Work; analytical method; base; capsule; design; human subject; improved; stability testing; uptake

Biological Testing Facility - Dimethandrolone Undecanoate (DMAU) contraceptive and further APis Manufacture, Formulation, Stability and Testing Biological Testing Facility is designed to permit rapid evaluation of new compositions of matter, drug formulations, delivery systems, and devices for anti-fertility or contraceptive and endocrine activity.

生物试验机构-二甲雄龙十一酸酯（DMAU）避孕药和其他 原料药生产、配制、稳定性和检测 生物试验设施的目的是允许快速评价新的物质成分， 用于抗生育或避孕和内分泌活性的药物制剂、递送系统和装置。